178 related articles for article (PubMed ID: 7796395)
1. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
Tahara H; Nakanishi T; Kitamoto M; Nakashio R; Shay JW; Tahara E; Kajiyama G; Ide T
Cancer Res; 1995 Jul; 55(13):2734-6. PubMed ID: 7796395
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of telomerase activity in hepatocellular carcinoma.
Ohta K; Kanamaru T; Yamamoto M; Saitoh Y
Kobe J Med Sci; 1996 Jun; 42(3):207-17. PubMed ID: 8973088
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.
Ogami M; Ikura Y; Nishiguchi S; Kuroki T; Ueda M; Sakurai M
Lab Invest; 1999 Jan; 79(1):15-26. PubMed ID: 9952107
[TBL] [Abstract][Full Text] [Related]
4. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
[TBL] [Abstract][Full Text] [Related]
5. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
[TBL] [Abstract][Full Text] [Related]
6. [Telomerase activity in liver cancer and the adjacent tissue].
Fu J; Zhang W; Jin S
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):434-6. PubMed ID: 10920937
[TBL] [Abstract][Full Text] [Related]
7. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues.
Kawakami Y; Kitamoto M; Nakanishi T; Yasui W; Tahara E; Nakayama J; Ishikawa F; Tahara H; Ide T; Kajiyama G
Oncogene; 2000 Aug; 19(34):3888-93. PubMed ID: 10951582
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
[TBL] [Abstract][Full Text] [Related]
10. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
Lee CM; Hsu CY; Eng HL; Huang WS; Lu SN; Changchien CS; Chen CL; Cho CL
Hepatogastroenterology; 2004; 51(57):796-800. PubMed ID: 15143919
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of telomerase activity in resected hepatocellular carcinoma.
Kanamaru T; Yamamoto M; Morita Y; Itoh T; Kuroda Y; Hisatomi H
Int J Mol Med; 1999 Sep; 4(3):267-71. PubMed ID: 10425277
[TBL] [Abstract][Full Text] [Related]
13. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
14. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259
[TBL] [Abstract][Full Text] [Related]
17. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T
Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
[TBL] [Abstract][Full Text] [Related]
18. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T
Cancer; 2000 Jan; 88(2):312-7. PubMed ID: 10640962
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in precancerous hepatic nodules.
Hytiroglou P; Kotoula V; Thung SN; Tsokos M; Fiel MI; Papadimitriou CS
Cancer; 1998 May; 82(10):1831-8. PubMed ID: 9587114
[TBL] [Abstract][Full Text] [Related]
20. Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas.
Tsuei DJ; Chang MH; Chen PJ; Hsu TY; Ni YH
J Med Virol; 2002 Dec; 68(4):513-21. PubMed ID: 12376959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
